TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/5/24 16:04 | 9/3/24 | SYRE | Spyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | S | -522 | 28.17 | 0 | -19 | -14 | 116 | D | ||||||||||||||
3/8/23 16:29 | 3/6/23 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | CA | O | CFO | S | -4 | 15.26 | 0 | 0 | 0 | 59 | D | ||||||||||||||
3/2/23 19:05 | 2/28/23 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | CA | O | CFO | S.m | -29 | 15.90 | 0 | -2 | -5 | 38 | D | ||||||||||||||
9/20/22 16:37 | 9/16/22 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | CA | O | CFO | M.d | 8 | 1.68 | 0 | 5 | 14 | 40 | D | ||||||||||||||
3/7/22 20:49 | 3/4/22 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | CA | O | CFO | S.dm | -5 | 16.85 | 0 | 0 | -1 | 35 | D | ||||||||||||||
3/3/22 16:17 | 3/1/22 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | CA | O | CFO | S | -7 | 17.75 | 0 | 0 | -2 | 22 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |